RI
RTW Investments Portfolio holdings
AUM
$7.02B
This Quarter Return
-5.88%
1 Year Return
+28.16%
3 Year Return
+245.48%
5 Year Return
+425.65%
10 Year Return
+5,642.23%
AUM
$265M
AUM Growth
+$265M
(-19%)
Cap. Flow
-$4.13M
Cap. Flow
% of AUM
-1.56%
Top 10 Holdings %
Top 10 Hldgs %
77.53%
Holding
39
New
3
Increased
15
Reduced
10
Closed
6
Top Buys
| 1 |
Bristol-Myers Squibb
BMY
|
$20.8M |
| 2 |
PTC Therapeutics
PTCT
|
$10.9M |
| 3 |
MDCO
Medicines Co
MDCO
|
$8.53M |
| 4 |
United States Oil Fund
USO
|
$7.91M |
| 5 |
OXFD
Oxford Immunotec Global PLC Ordinary Shares
OXFD
|
$4.6M |
Top Sells
| 1 |
Incyte
INCY
|
$10.5M |
| 2 |
SPDR Gold Trust
GLD
|
$10.4M |
| 3 |
Arrowhead Research
ARWR
|
$8.21M |
| 4 |
ACHN
Achillion Pharmaceuticals, Inc.
ACHN
|
$7.94M |
| 5 |
Heron Therapeutics
HRTX
|
$6.66M |
Sector Composition
| 1 | Healthcare | 89.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
AVXS
1
DELISTED
AveXis, Inc. Common Stock
AVXS
| $40.5M | 15.25% | 849,043 +23,063 | +3% | +$1.1M |
|
|
2
Bristol-Myers Squibb
BMY
$96B
| $33.1M | 12.45% | 565,888 +356,187 | +170% | +$20.8M |
|
3
Alnylam Pharmaceuticals
ALNY
$58.5B
| $29.5M | 11.12% | 789,208 -159,078 | -17% | -$5.96M |
|
4
BioCryst Pharmaceuticals
BCRX
$1.74B
| $25.8M | 9.72% | 4,078,895 -125,684 | -3% | -$796K |
|
|
LJPC
5
DELISTED
La Jolla Pharmaceutical Company
LJPC
| $19M | 7.17% | 1,086,037 -84,114 | -7% | -$1.47M |
|
|
AGEN
6
Agenus
AGEN
$133M
| $17.3M | 6.53% | 4,210,264 +68,620 | +2% | +$283K |
|
|
MDCO
7
DELISTED
Medicines Co
MDCO
| $12.7M | 4.78% | 374,263 +251,263 | +204% | +$8.53M |
|
|
8
PTC Therapeutics
PTCT
$3.92B
| $10.9M | 4.1% | +997,166 | New | +$10.9M |
|
|
9
Incyte
INCY
$16.5B
| $8.7M | 3.27% | 86,757 -104,394 | -55% | -$10.5M |
|
|
OXFD
10
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
| $8.12M | 3.06% | 543,287 +307,387 | +130% | +$4.6M |
|
|
11
United States Oil Fund
USO
$967M
| $7.91M | 2.98% | +675,000 | New | +$7.91M |
|
|
BLUE
12
DELISTED
bluebird bio
BLUE
| $7.56M | 2.85% | 122,576 +34,842 | +40% | +$2.15M |
|
|
DRNA
13
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $5.88M | 2.21% | 2,043,216 +16,322 | +0.8% | +$47K |
|
14
Masimo
MASI
$7.59B
| $5.45M | 2.05% | 80,900 +55,000 | +212% | +$3.71M |
|
15
Atara Biotherapeutics
ATRA
$84.6M
| $5.29M | 1.99% | 372,624 -85,489 | -19% | -$1.21M |
|
|
CORI
16
DELISTED
Corium International, Inc.
CORI
| $4.47M | 1.68% | 1,101,045 +55,298 | +5% | +$224K |
|
17
Regenxbio
RGNX
$451M
| $4.45M | 1.67% | 239,789 +1,049 | +0.4% | +$19.5K |
|
|
VIVE
18
DELISTED
VIVEVE MED INC
VIVE
| $4.32M | 1.63% | 839,666 +392 | +0% | +$2.02K |
|
19
Tactile Systems Technology
TCMD
$297M
| $4.08M | 1.54% | 248,762 +21,163 | +9% | +$347K |
|
|
IVTY
20
DELISTED
Invuity, Inc
IVTY
| $2.62M | 0.98% | 454,900 +62,062 | +16% | +$357K |
|
21
Omeros
OMER
$283M
| $2.57M | 0.97% | 259,039 -123,973 | -32% | -$1.23M |
|
|
ACHN
22
DELISTED
Achillion Pharmaceuticals, Inc.
ACHN
| $1.18M | 0.44% | 286,285 -1,922,464 | -87% | -$7.94M |
|
23
Celldex Therapeutics
CLDX
$1.47B
| $848K | 0.32% | 239,662 -1,003,502 | -81% | -$3.55M |
|
24
Sensus Healthcare
SRTS
$55.7M
| $645K | 0.24% | 122,803 -2,897 | -2% | -$15.2K |
|
|
MRTX
25
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $616K | 0.23% | 129,697 +568 | +0.4% | +$2.7K |
|